Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cancer Medicine|May 14, 2025
EIF2S1 in Urinary Extracellular Vesicles as a Novel Diagnostic Marker for Bladder CancerEisuke Tomiyama, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Oncotarget|May 15, 2018
Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinomaYoshiyuki Yamamoto, Motohide Uemura, Kosuke Nakano, et al.
Translational Andrology and Urology|May 10, 2021
MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancerKyosuke Matsuzaki, Kazutoshi Fujita, Eisuke Tomiyama, et al.
Plos One|August 10, 2018
STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinomaKyosuke Matsuzaki, Kazutoshi Fujita, Yujiro Hayashi, et al.
Oncology Reports|November 29, 2018
Leukocyte‑associated immunoglobulin‑like receptor 1 promotes tumorigenesis in RCCKentaro Jingushi, Motohide Uemura, Kosuke Nakano, et al.
International Journal of Clinical Oncology|January 20, 2021
The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective studyTaigo Kato, Akira Nagahara, Norihiko Kawamura, et al.
Anticancer Research|November 4, 2021
Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell CarcinomaTaigo Kato, Akira Nagahara, Norihiko Kawamura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 29, 2022
A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in JapanTaigo Kato, Satoru Yumiba, Wataru Nakata, et al.
Cancer Science|October 7, 2017
Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinomaToshiro Kinouchi, Motohide Uemura, Cong Wang, et al.
Frontiers in Oncology|June 9, 2020
Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder CancerYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Pageof 4